Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
J Endocrinol Invest ; 47(4): 857-864, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37752372

ABSTRACT

PURPOSE: To characterize patients with APS and to propose a new approach for their follow-up. Query ID="Q1" Text="Please check the given names and familynames." METHODS: Monocentric observational retrospective study enrolling patients referred to the Outpatients clinic of the Units of Endocrinology, Diabetology, Gastroenterology, Rheumatology and Clinical Immunology of our Hospital for Autoimmune diseases. RESULTS: Among 9852 patients, 1174 (11.9%) [869 (73.9%) female] were diagnosed with APS. In 254 subjects, the diagnosis was made at first clinical evaluation (Group 1), all the other patients were diagnosed with a mean latency of 11.3 ± 10.6 years (Group 2). Group 1 and 2 were comparable for age at diagnosis (35.7 ± 16.3 vs. 40.4 ± 16.6 yrs, p = .698), but different in male/female ratio (81/173 vs 226/696, p = .019). In Group 2, 50% of patients developed the syndrome within 8 years of follow-up. A significant difference was found after subdividing the first clinical manifestation into the different outpatient clinic to which they referred (8.7 ± 8.0 vs. 13.4 ± 11.6 vs. 19.8 ± 8.7 vs. 7.4 ± 8.1 for endocrine, diabetic, rheumatologic, and gastroenterological diseases, respectively, p < .001). CONCLUSIONS: We described a large series of patients affected by APS according to splitters and lumpers. We propose a flowchart tailored for each specialist outpatient clinic taking care of the patients. Finally, we recommend regular reproductive system assessment due to the non-negligible risk of developing premature ovarian failure.


Subject(s)
Autoimmune Diseases , Endocrinology , Polyendocrinopathies, Autoimmune , Primary Ovarian Insufficiency , Humans , Female , Male , Retrospective Studies , Polyendocrinopathies, Autoimmune/diagnosis
2.
J Endocrinol Invest ; 41(11): 1301-1306, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29582344

ABSTRACT

PURPOSE: To compare TSH levels of hypothyroid patients treated with liquid LT4 at breakfast or 30 min before breakfast. PATIENTS AND METHODS: Subjects, aged 18-75 years old, were eligible if they presented hypothyroidism, due to Hashimoto's thyroiditis or after thyroidectomy for proven benign goiter. Seven hundred ninety-eight patients were recruited and enrolled in the study. Thirty-seven subjects withdrew from the trial. A total of 761 patients (mean age 46.2 ± 10.8 years) completed the study. The starting dose of LT4 was determined through clinical judgment, taking into account TSH levels, estimated residual thyroid function, age, body weight and comorbidities. All patients underwent TSH, fT4, and fT3 evaluation to verify achievement of euthyroidism with their initial fasting state assumption of LT4 after 8 weeks of therapy. If euthyroidism was not achieved, an appropriately adjusted LT4 dose was administered for 8 weeks, after which thyroid function parameters were checked again. If euthyroidism was achieved, the patients were asked to take LT4 at breakfast and hormone levels were checked again after 6 months. RESULTS: At the end of the study period, no significant differences in serum TSH level were observed whether LT4 was ingested at breakfast or 30 min prior in a fasting state: 2.61 ± 1.79 vs. 2.54 ± 1.86 mIU/L, respectively (p = 0.455). CONCLUSIONS: This study confirms in a large set of patients that a liquid LT4 formulation can be taken directly at breakfast and potentially improve therapeutic compliance.


Subject(s)
Hormone Replacement Therapy , Hypothyroidism/blood , Thyrotropin/blood , Thyroxine/therapeutic use , Adult , Breakfast , Drug Administration Schedule , Fasting , Female , Humans , Hypothyroidism/drug therapy , Male , Middle Aged , Thyroxine/administration & dosage , Treatment Outcome
3.
Br J Oral Maxillofac Surg ; 55(3): 266-269, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27938945

ABSTRACT

Although fine-needle aspiration (FNA) cytology of thyroid nodules is invasive, it is simple, reliable, safe, and well-accepted by patients. Local pain and minor haematomas are the most common complications, and serious ones are rare. We report the complications associated with ultrasound-guided FNA of 7449 thyroid nodules in a series of 6323 patients (5121 women and 1202 men) treated between January 2007 and March 2016 at our institution. We reviewed their medical and imaging records, and recorded the number and type of complications, time of detection, time to recovery, management, and permanent consequences. Ten patients (0.15%) had complications, which included a focal carotid intramural haematoma that spread along the carotid wall for 7cm in a young patient, and one case of tumour seeding. No complications caused permanent problems. This series shows that ultrasound-guided FNA of thyroid lesions is safe and has few complications. However, physicians should always consider the risks and benefits for each patient before the procedure.


Subject(s)
Postoperative Complications/etiology , Thyroid Nodule/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle/adverse effects , Female , Humans , Image-Guided Biopsy , Male , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Ultrasonography, Interventional , Young Adult
4.
Acta Radiol ; 55(4): 429-33, 2014 May.
Article in English | MEDLINE | ID: mdl-23969266

ABSTRACT

BACKGROUND: High resolution ultrasonography features have also been described as having a useful supporting role in the diagnosis of subacute granulomatous thyroiditis (ST), and images are generally characterized by heterogeneous hypoechoic areas of the affected tissue with lack of flow on color Doppler US. PURPOSE: To determine the sonographic features of subacute granulomatous thyroiditis. MATERIAL AND METHODS: We reviewed the medical records of patients referred at the Endocrine and Metabolic Unit of our Institution between January 2010 and December 2011. RESULTS: A total of 7520 patients were evaluated in our department between January 2010 and December 2011. Among them, 22 (0.3%) patients had a diagnosis of ST (19 women and 3 men, 45.4 ± 9.7 year; range, 33-62 years). Ultrasound examination showed bilateral ST in 64% of patients. Thyroid volume was 13.2 ± 7.7 mL, without difference if ST was unilateral (13.2 ± 7.1 mL) or bilateral (13.9 ± 8.3 mL). On grayscale US, heterogeneous diffusely or focally marked hypoechoic areas, like "lava flow", were found in all the lesions. CONCLUSION: Our data confirm the high sensitivity of US in the diagnosis of ST: diffuse hypoechoic and confluent areas with the characteristic features like "lava flow".


Subject(s)
Thyroiditis, Subacute/diagnostic imaging , Adult , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Retrospective Studies , Thyroiditis, Subacute/pathology , Ultrasonography
5.
J Endocrinol Invest ; 35(5): 459-63, 2012 May.
Article in English | MEDLINE | ID: mdl-22067268

ABSTRACT

BACKGROUND: The European Thyroid Association (ETA) and the American Thyroid Association (ATA) guidelines identify subgroups of patients affected by thyroid carcinoma in whom, due to a low risk of recurrence, radioiodine ablation is not indicated. These patients are referred to as "very low-risk" according to the ETA consensus and "low-risk" patients according to the ATA guidelines. The recommended post-surgical follow-up of these patients is based upon periodical measurements of serum thyroglobulin (Tg) on levothyroxine therapy and neck ultrasound (US). AIM: To evaluate the usefulness of recombinant human (rh)-TSH Tg test and its repetition 2-3 yr afterwards in very low-risk patients. MATERIALS AND METHODS: We consecutively enrolled 32 patients with undetectable anti-Tg antibodies. Basal serum Tg levels was undetectable in all patients. RESULTS: Following rhTSH serum Tg remained undetectable in 23 (71.9%) patients (UP) and was >1.0 ng/ml in 9 (DP). US and whole body scan, revealed lymph node metastasis in 4/9 DP patients. A second rhTSH stimulation test (36.9±3.5 months later) was performed in all UP and in 5 DP patients without proven recurrences. All the UP and 4/5 formerly DP patients showed undetectable Tg stimulation. CONCLUSIONS: Our results suggest that rhTSH Tg test may be helpful in very low-risk patients, given its ability to differentiate those who may be considered "free of disease" from those who require further investigation and treatment. Repeated rhTSH Tg tests may be indicated only in patients with detectable serum Tg at prior stimulation testing.


Subject(s)
Thyroglobulin/blood , Thyroid Neoplasms/blood , Thyrotropin Alfa , Adenocarcinoma, Papillary/blood , Adenocarcinoma, Papillary/diagnosis , Adenocarcinoma, Papillary/surgery , Biological Assay/statistics & numerical data , Cell Differentiation , Female , Follow-Up Studies , Humans , Iodine Radioisotopes , Male , Middle Aged , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/surgery , Prognosis , Prospective Studies , Risk Factors , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/surgery , Thyrotropin
6.
Article in English | MEDLINE | ID: mdl-20582776

ABSTRACT

The aim of this research was to determine the fate of aflatoxins (AFs) and fumonisins (FBs) naturally occurring in raw materials (maize grit and malted barley) during four industrial brewing processes. The aflatoxin B(1) (AFB(1)) level in raw materials varied from 0.31 to 14.85 microg kg(-1), while the fumonisin B(1) (FB(1)) level (only in maize grit) varied from 1146 to 3194 microg kg(-1). The concentration in finished beer ranged from 0.0015 to 0.022 microg l(-1) for AFB(1) and from 37 to 89 microg l(-1) for FB(1); the other aflatoxins and fumonisin B(2) were not found in beer samples. The average percentage of toxins recovered in finished beer, referring to the amounts contained in raw materials, were 1.5% +/- 0.8% for AFB(1) and 50.7% +/- 4.7% for FB(1). These results were mainly due to the different solubility of the two mycotoxins during the mashing process. If raw materials comply with the limits fixed by European Commission Regulations, the contribution of a moderate daily consumption of beer to AFB(1) and FB(1) intake does not contribute significantly to the exposure of the consumer.


Subject(s)
Aflatoxin B1/analysis , Beer/analysis , Food Contamination/analysis , Fumonisins/analysis , Carcinogens, Environmental/analysis , Chromatography, High Pressure Liquid , Chromatography, Liquid , Food Handling , Hordeum/chemistry , Italy , Mass Spectrometry , Quality Control , Zea mays/chemistry
7.
QJM ; 101(8): 657-62, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18499732

ABSTRACT

Surgery is the treatment of choice for symptomatic primary hyperparathyroidism; unlikely few patients do not meet established surgical criteria or have comorbid conditions that prohibit surgery. In these subjects, medical therapy alone offers little hope for a sustained long normocalcemic period. However percutaneous ethanol injection (PEI) may represent an alternative therapeutic procedure. It is currently in use for the treatment of secondary or tertiary hyperparathyroidism, however, few studies or case reports suggest it for the treatment of primary hyperparathyroidism. Moreover, little information is available about the long-term follow-up, where incomplete necrosis or the spreading of ethanol in the surrounding tissues is often reported. We believe that many of the side effects could be correlated to procedure itself. Taking these experiences into account, we have reasoned that in order to limit these side effects, we had to modify the standard PEI procedure. We reported this preliminary experience describing our modified PEI procedure.


Subject(s)
Adenoma/therapy , Ethanol/administration & dosage , Hyperparathyroidism, Primary/therapy , Parathyroid Neoplasms/therapy , Solvents/administration & dosage , Adenoma/diagnostic imaging , Aged , Female , Humans , Hyperparathyroidism, Primary/diagnostic imaging , Injections, Intralesional , Middle Aged , Parathyroid Neoplasms/diagnostic imaging , Treatment Outcome , Ultrasonography, Interventional
8.
J Endocrinol Invest ; 31(1): 25-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18296901

ABSTRACT

Ultrasound fine needle aspiration cytology (US-FNAC) represents the most effective test available to distinguish between benign and malignant thyroid nodules, with an accuracy approaching 95%. The major limit of this procedure it is the rate of inadequate specimens which is reported to be from 10% to 31%. Also because cost considerations have always been important and have recently become even more relevant for clinical guidelines in many countries, it is desirable to limit the number of inadequate samples. Recently, we have shown that the use of stylet needles greatly reduces inadequate cytological specimens in thyroid nodules with an intranodular vascular pattern. With the aim to improve our previous results, we have extended our procedure to all thyroid solid nodules. Between February 2004 and March 2006, 312 consecutive patients with thyroid nodule without intranodular vascular pattern at color-Doppler evaluation were enrolled in this prospective study. US-FNAC was performed by two different 25 gauge needles (Neolus [Ns] and Yale Spinal [YS]), and the two procedures were performed in alternate sequence on consecutive patients. Adequate specimens were observed in 145 (92.9%) and 153 (98%) nodules respectively investigated by Ns and in YS (p<0.005). The total cost to obtain a cytological diagnosis by Ns was of euro 12210.2 (156+12 repeated US-FNAC), whereas it was of euro 12449.7 by YS (156+3 repeated US-FNAC). Our data suggest that spinal needles are associated with a low proportion of inadequate FNAC, without increase of total direct cost, considering also the number of FNAC repetitions needed; therefore, their routine use could be taken into account.


Subject(s)
Biopsy, Fine-Needle/instrumentation , Needles , Thyroid Nodule/diagnosis , Thyroid Nodule/pathology , Adult , Biopsy, Fine-Needle/economics , Cost-Benefit Analysis , Female , Humans , Male , Middle Aged , Needles/economics , Quality Control , Single-Blind Method , Specimen Handling , Ultrasonography, Interventional
9.
Eur J Radiol ; 65(1): 99-103, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17459638

ABSTRACT

According to many guidelines, scintigraphy remains the first suggested diagnostic procedure in hyperthyroid patients in spite of the widespread availability of ultrasounds. The aim of this study was to evaluate the cost-effectiveness of sonography versus scintigraphy in the management of Graves's disease, and to assess ultrasound features suggesting cancer in detecting thyroid nodules. Among 1470 hyperthyroid patients evaluated in our department from 2002 to 2005, 426 (29%) had Graves' disease: echographic and scintigraphic features were not suggestive of GD in 20/426 (4.8%) and 11/426 (2.6%) patients, respectively (p=0.763), even if one of the two procedures was almost always diagnostic. Ultrasound identified 68/426 (16%) patients with a concomitant solid lesion, while scintigraphy detected only 9/426 (2.1%) "cold" nodules (p<0.001). Thyroid cancer was diagnosed in 30/68 (47.7%) patients. Malignancy presented at ultrasound investigation blurred margins (26.7% versus 15.8%), microcalcifications (33.3% versus 28.9%) and an anteroposterior and transverse diameter ratio>or=1 (73.3% versus 71.1%); more frequently than benign nodules, but this was not statistically significant. The total cost to obtain a diagnosis by ultrasound was euro14645.34 (euro13312.5 for echography+euro1332.84 for scintigraphy in the 29 patients "negative" at echographic evaluation for GD) versus euro19922.71 by scintigraphy (euro19578.96 for scan+euro343.75 for ultrasounds in the 11 patients "negative" at scintigraphy). Our data show no difference in terms of diagnosis between sonography and scintigraphy. Indeed, scintigraphy was less sensitive in detecting nodules (often of malignant nature) than ultrasound, and, moreover, with a consequent increase of the direct cost of nodule management when scintigraphy is the first line procedure. In conclusion, according to our results, we suggest that ultrasounds with color-Doppler evaluation should be performed as first step in all hyperthyroid patients, and that scintigraphic examination should be limited only to the uncommon cases, where physician's observation, laboratory assays and/or ultrasounds are not diagnostic.


Subject(s)
Graves Disease/diagnostic imaging , Tomography, Emission-Computed/economics , Ultrasonography, Doppler, Color/economics , Chi-Square Distribution , Female , Graves Disease/pathology , Humans , Male , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity
10.
Eur J Endocrinol ; 157(4): 529-32, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17893269

ABSTRACT

OBJECTIVE: To evaluate whether a preliminary aspiration (ASP) of the cystic component and/or using spinal needles in complex thyroid nodules (CTN) could improve the adequacy of cytological sampling. METHODS: Between January 2004 and December 2006, 386 consecutive patients with CTN were enrolled in this prospective investigation. Ultrasound (US) fine needle aspiration cytology (FNAC) of the solid component of the nodule (one nodule per patient) was performed using two different 25 gauge needles, with (Yale Spinal, YS) or without (Neolus, NS) a stylet, in alternate sequence on consecutive patients. In addition, a subgroup of patients presenting larger cystic component (approximately 50%) was submitted to total aspiration of the cystic component (ASP+) or not submitted (ASP-) before US-FNAC, in alternate sequence within each needle type group. All the samplings were performed by a single endocrinologist. RESULTS: Adequate specimens were observed in 163 (84.5%) and 183 (94.8%) nodules investigated by NS and YS respectively. Sampling with the stylet needle was associated with an overall significant reduction of non-diagnostic specimens (15.5% vs 5.2% by NS and YS respectively, P < 0.001). The favourable result obtained with YS was independent from preliminary aspiration of the cystic component (ASP+: 14.8% vs 5.7% by NS and YS; ASP-: 16.2% vs 4.8%, not significant). A logistic regression analysis, taking into account nodule size and presence of intranodal vascularity at eco-colour evaluation of the solid component, confirmed that needle type was the only significant predictor of successful sampling (odds ratio 3.6 (95% confidence interval 1.7-7.6), P < 0.001). CONCLUSIONS: Our data show that adopting stylet needles to perform FNAC in CTN may significantly improve the percentage of adequate sampling. On the other hand, preliminary aspiration of CTN with large cystic component does not add any advantage.


Subject(s)
Biopsy, Fine-Needle , Thyroid Nodule/diagnosis , Thyroid Nodule/pathology , Ultrasonography, Interventional/methods , Adult , Aged , Biopsy, Fine-Needle/adverse effects , Biopsy, Fine-Needle/instrumentation , Female , Humans , Male , Middle Aged , Sensitivity and Specificity , Ultrasonography, Interventional/adverse effects
11.
J Surg Oncol ; 95(7): 555-60, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17226813

ABSTRACT

BACKGROUND: Papillary thyroid carcinoma (PTC) represents 70%-75% of well-differentiated thyroid cancers. Although most reports have shown that papillary thyroid microcarcinomas (PMC) follow an indolent course, a few series have demonstrated that a significant number of them are associated with extrathyroidal extension and nodal or distant metastases. METHODS: Four hundred eighty-four patients with papillary thyroid cancer (102, PMC; 382, PTC) were enrolled in this study. The median follow-up was 102 months. RESULTS: No difference between PTC and PMC patients was observed for age, gender, multifocality, extrathyroidal extension, and lymph nodes metastasis. The prevalence of nodal involvement developing during the follow-up period was significantly higher in PMC than PTC (58.8% vs. 38.5%, P = 0.002). An unfavorable clinical course occurred in 96 subjects (21.8%). Logistic analysis showed that the strongest association with the worst prognosis was found for age and TNM stage III (P < 0.001). Analysis also confirmed that the presence of intranodular vascularity is a predictor of unfavorable outcome (P = 0.044). CONCLUSIONS: We suggest always performing a total thyroidectomy followed by radiometabolic therapy in papillary carcinomas independent of their size. If the choice in PMCs should be more conservative (hemithyroidectomy), we purpose to limit this procedure to the cancers without Doppler features suggesting intranodular vascular pattern.


Subject(s)
Carcinoma, Papillary/pathology , Thyroid Neoplasms/pathology , Thyroidectomy , Adult , Biopsy, Fine-Needle , Carcinoma, Papillary/radiotherapy , Carcinoma, Papillary/secondary , Carcinoma, Papillary/surgery , Female , Humans , Iodine Radioisotopes/therapeutic use , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prognosis , Radiopharmaceuticals/therapeutic use , Radiotherapy, Adjuvant , Thyroid Gland/diagnostic imaging , Thyroid Gland/pathology , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery , Thyroidectomy/methods , Treatment Outcome , Ultrasonography
12.
QJM ; 100(1): 29-35, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17178736

ABSTRACT

BACKGROUND: Thyroid nodules are a common medical problem, but whether fine-needle aspiration cytology (FNAC) is mandated for smaller non-palpable nodules, is controversial. AIM: To evaluate whether ultrasonographic features of thyroid nodules are associated with histological malignancy, and to identify useful criteria for clinical decision-making. DESIGN: Prospective observational study. METHODS: From January 1991 to September 2004, 5198 patients were referred to our hospital for ultrasound evaluation of thyroid nodules. Overall, 7455 nodules (diameters from 6 to 100 mm) were examined; 2865 (38.4%) were <10 mm in diameter. All patients with suspicious or malignant cytology underwent surgery. RESULTS: Of the 349 nodules undergoing surgery, 284 were malignant. The prevalence of cancer was slightly higher in nodules>or=10 mm in diameter vs. those<10 mm (5.5% vs. 3.0%, p<0.01). However, histological type and local aggressiveness were largely independent of nodule size. Microcalcifications (72.2% vs. 28.7%; p<0.001; OR 6.4, 95%CI 4.9-8.4), blurred margins (52.8% vs. 18.8%; p<0.001; OR 4.8, 95%CI 3.8-6.1), solid hypoechoic appearance (80.6% vs. 52.4%; p<0.001; OR 3.8, 95%CI 2.8-5.1), size>or=10 mm (77.4% vs. 64.9%; p<0.001; OR 1.9, 95%CI 1.4-2.5) and intranodular vascular pattern type 2 (61.6% vs. 49.7%; p<0.001; OR 1.6, 95%CI 1.2-2.0) were all significantly more frequent in malignant than in benign nodules. These associations were similar when large and small nodules were analysed separately. DISCUSSION: No single parameter, including nodule size, satisfactorily identifies a subset of patients to be electively investigated by FNAC, although several may be useful in this regard.


Subject(s)
Thyroid Neoplasms/diagnostic imaging , Thyroid Nodule/diagnostic imaging , Ultrasonography, Doppler, Color , Biopsy, Fine-Needle , Female , Humans , Male , Odds Ratio , Prospective Studies , Thyroid Neoplasms/epidemiology , Thyroid Neoplasms/pathology , Thyroid Nodule/pathology
13.
Ann Endocrinol (Paris) ; 67(3): 245-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16840916

ABSTRACT

Ectopic thyroid tissue with thyroid gland in its normal location is an extremely rare phenomenon. We present a case of a 38-year-old woman who was referred to our hospital with symptoms of hypothyroidism. Thyroid hormone measurement revealed clinical hypothyroidism with elevated anti-thyroid antibodies, neck ultrasonography showed a small tissue with the characteristic of Hashimoto thyroiditis, while the scintigraphy demonstrated only a lingual thyroid. Treatment consisted in L-thyroxine replacement to the euthyroid state. We reviewed the literature with respect to the embryological background and the clinical management of such cases.


Subject(s)
Choristoma/pathology , Hypothyroidism/etiology , Thyroid Gland , Tongue Diseases/pathology , Female , Hashimoto Disease/pathology , Humans , Hypothyroidism/drug therapy , Hypothyroidism/pathology , Middle Aged , Neck/diagnostic imaging , Technetium , Thyroxine/therapeutic use , Ultrasonography
14.
Endocr Pathol ; 16(4): 349-54, 2005.
Article in English | MEDLINE | ID: mdl-16627921

ABSTRACT

OBJECTIVE: To compare the cytological findings of hypoechoic thyroid nodules with intranodular vascular pattern (pattern II) obtained by two different needles (Neolus 25 gauge, Chemil, Wenzhou, China vs Yale Spinal 25 gauge, Becton Dickinson, Madrid, Spain) in euthyroid patients and to evaluate their cost-effectiveness. METHODS: From January 2001 to December 2003, 480 euthyroid patients with a hypoechoic thyroid nodule pattern II were referred for US-FNAC. The nodules were alternatively evaluated by Neolus or by Yale Spinal with the stylet (YS+) or without the stylet (YS-), in order to evaluate if the cytological results could be due to the presence of the stylet or to the different length of the two needles. For each nodule two passes were performed and the material was obtained by capillary action. Material was smeared on slides, fixed, and stained by Papanicolaou techniques. Cytological specimens were evaluated in blind by the same experienced cytopathologist. RESULTS: Inadequate cytological specimens because of blood contamination were present in 30 (18.7%) samples by Neolus needle and in 22 (13.8%) by YS- compared to only 5 (3.1%) by YS+. In 6 (20%) cases of the 30 repeated US-FNAC by Neolus and in 4 (18%) of the 22 US-FNAC by YS-, material remained inadequate for diagnosis because of blood contamination. All the five repeated samples obtained by YS+ became adequate for diagnosis and resulted benign nodules. Direct costs of US-FNAC procedure are currently 72.30 Euro including cytological examination. The cost of Neolus and Yale needles is 0.19 Euro and 3.0 Euro, respectively. The estimated total cost to obtain a cytological diagnosis by a Neolus needle (160 + 30 repeated US-FNAC) was 13809.2 Euro vs 12919.5 Euro by Yale Spinal needle (160 + 5 repeated US-FNAC). CONCLUSION: This study demonstrates that the use of Yale Spinal needles greatly reduces inadequate cytological specimens, and therefore limits both direct and indirect costs.


Subject(s)
Biopsy, Fine-Needle/economics , Biopsy, Fine-Needle/instrumentation , Needles/economics , Thyroid Nodule/blood supply , Thyroid Nodule/surgery , Cost-Benefit Analysis , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity , Thyroid Nodule/diagnosis
15.
Minerva Endocrinol ; 29(1): 1-10, 2004 Mar.
Article in Italian | MEDLINE | ID: mdl-15258552

ABSTRACT

AIM: Calcitonin is a hormone secreted by thyroid C-cells. Its primary effect seems to be a direct inhibition of bone degradation, but the physiological function of calcitonin in humans is still uncertain. The role of this hormone in the development of osteoporosis is unknown, but few authors have shown bone mass reduction in thyroidectomy patients. METHODS: To investigate the influence of calcitonin deficiency on bone turnover, 9 males (age 31 to 66 years) submitted to total thyroidectomy in 1996 for non-toxic goitre have been studied. These patients received thyroxine treatment at individual dose but never with suppressed TSH levels. Moreover 8 sex-, age- and Body Mass Index-matched normal subjects have also been studied as control group. RESULTS: Calcitonin was undetectable in thyroidectomized patients, while the mean value was 7.1+/-3.2 pg/ml in the control group. At bone ultrasonography 50% of patients showed osteopenia, while only 1 subject showed osteopenia in the control group. The mean calcium serum level of patients was significant lower than in the control group (p<0.001). Calcium urinary level was increased in patients than controls. PTH serum levels were statistically decreased (p<0.001) in patients more than in controls. Osteocalcin showed a significantly (p<0.05) lower bone formation in patients than in controls, while the markers of resorption, deoxypyridinoline and N-terminal telopeptide of type I collagen, suggested an increased bone turnover in calcitonin-deficiency patients. CONCLUSION: The results of this study show that the chronic lack of calcitonin in total thyroidectomized patients may play a role in increased bone degradation and osteopenia with a higher risk of bone fracture.


Subject(s)
Bone Density , Bone Diseases, Metabolic/etiology , Bone and Bones/metabolism , Calcitonin/deficiency , Minerals/metabolism , Postoperative Complications/metabolism , Adult , Aged , Biomarkers , Bone Diseases, Metabolic/metabolism , Bone Resorption/etiology , Bone Resorption/metabolism , Case-Control Studies , Fingers/diagnostic imaging , Goiter, Nodular/surgery , Humans , Hypocalcemia/etiology , Hypocalcemia/metabolism , Male , Middle Aged , Osteocalcin/blood , Parathyroid Hormone/blood , Parathyroid Hormone/deficiency , Thyroidectomy/adverse effects , Ultrasonography
16.
Minerva Endocrinol ; 29(1): 19-24, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15258554

ABSTRACT

Somatostatin producing duodenal carcinoids are rare, comprising a mere 2% of small bowel carcinoids and 5-10% of all duodenal tumors. Since the 1st case described by Kaneko in 1979 more than 50 cases have been reported in the world literature. From these reports, it is gradually emerging that duodenal somatostatinomas may show a strong association with von Recklinhausen's neurofibromatosis (VRNF) as a distinct neuroendocrine syndrome. A case of a patient affected by VRNF associated with duodenal somatostatinoma with consequent obstructive jaundice is reported. The authors discuss the characteristics of these tumors and review the literature. A total of 27 patients with Von Recklinghausen's disease associated with immunohistologically proved duodenal somatostatinoma have been identified and compared with 29 duodenal somatostatinoma not associated with VRNF, and with 32 cases of pancreatic somatostatinomas.


Subject(s)
Duodenal Neoplasms/genetics , Neurofibromatosis 1 , Somatostatinoma/genetics , Adult , Ampulla of Vater/pathology , Cholangiopancreatography, Endoscopic Retrograde , Common Bile Duct/pathology , Duodenal Neoplasms/complications , Duodenal Neoplasms/diagnosis , Duodenal Neoplasms/surgery , Female , Humans , Jaundice, Obstructive/etiology , Pancreaticoduodenectomy , Skin Neoplasms/genetics , Somatostatinoma/complications , Somatostatinoma/diagnosis , Somatostatinoma/surgery
17.
Minerva Endocrinol ; 27(2): 65-71, 2002 Jun.
Article in Italian | MEDLINE | ID: mdl-11961499

ABSTRACT

BACKGROUND: The introduction of highly sensitive imaging techniques has made it possible to detect many non-palpable thyroid nodules with size less than 1 centimetre. The prevalence of these lesions appears to be high in the general population and increases in iodine deficiency areas. Fine needle aspiration biopsy (FNAB) is considered the most reliable test for the diagnosis of thyroid nodules. METHODS: From January 1991 to December 2000, 6627 nodules were referred for FNAB to our department. In 4871 (73.5%) euthyroid patients the mean daily urinary excretion of iodine was 73+/-18 micromg/day. RESULTS: In 2401 nodules (36.2%) the diameter was less than one centimetre. Histologic confirmation of malignancy was available in 187 (89.9%) of 208 operated nodules with diameter more than 1 cm and in 64 (78%) of 82 with diameter less than 1 cm. Logistic regression analysis indicated that a solid hypoechoic feature was a useful criterion to predict malignancy (p<0.001), as well as the presence of calcification (p<0.5) and blurred margins (p<0.5). Lymph node metastases were present in 24.3% of carcinomas with diameter more than 1 cm but, surprisingly, also in 20.3% of those with diameter less than 1 cm. No correlation was seen between diameter of carcinoma nodules and presence of lymph node metastasis. CONCLUSIONS: These data suggest that the potential malignancy of thyroid nodules is not only correlated to the diameter but to other parameters such as the biological difference of thyroid cancer that could be hypothesized in an iodine deficiency area. In conclusion, FNAB is recommended for nodules with diameter less than 1 centimetre when sonographic findings suggest malignancy such as a hypoechoic pattern, an irregular margin or internal microcalcification.


Subject(s)
Iodine/deficiency , Thyroid Neoplasms/epidemiology , Thyroid Nodule/epidemiology , Adenocarcinoma, Follicular/diagnostic imaging , Adenocarcinoma, Follicular/epidemiology , Adenocarcinoma, Follicular/pathology , Biopsy, Needle , Calcinosis/diagnostic imaging , Carcinoma, Medullary/diagnostic imaging , Carcinoma, Medullary/epidemiology , Carcinoma, Medullary/pathology , Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/epidemiology , Carcinoma, Papillary/pathology , Humans , Iodine/urine , Italy/epidemiology , Lymphatic Metastasis , Neoplasm Invasiveness , Prevalence , Retrospective Studies , Thyroid Hormones/blood , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/etiology , Thyroid Neoplasms/pathology , Thyroid Nodule/diagnostic imaging , Thyroid Nodule/etiology , Thyroid Nodule/pathology , Thyrotropin/blood , Ultrasonography
18.
Chir Ital ; 53(5): 645-52, 2001.
Article in Italian | MEDLINE | ID: mdl-11723895

ABSTRACT

Thyroid nodules are commonly found in clinical practice, and their detection by either the physician or the patients always gives rise to concern as to the possible existence of a malignancy. Technological developments have had a major impact on the study and treatment of thyroid nodules. The application of fine-needle aspiration biopsies (FNAB) and the availability of high-resolution thyroid ultrasonography have modified thyroid nodule management even if important differences of opinion remain. This article describes the progress as well as contemporary controversies in thyroid nodule diagnosis and considers the effect these advances have had on the treatment of patients with nodular disease. It includes a brief description of the clinical importance of thyroid nodules, of the use and limitations of imaging studies in thyroid nodule diagnosis and of the usefulness, limitations, and impact of FNAB on nodule management.


Subject(s)
Thyroid Nodule/diagnosis , Decision Trees , Hospital Departments , Humans , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...